NEW YORK (GenomeWeb News) – Thermo Fisher Scientific and the National University of Singapore today announced the signing of a memorandum of understanding to develop a strategic alliance to increase advance basic and applied research in Singapore.
The agreement covers the life sciences, healthcare, and applied markets, and includes cancer and diagnostics. Thermo Fisher and NUS will develop analytical technologies, reagents, instruments, and software, they said.
As part of the deal, Thermo Fisher will, for up to five years, sponsor short-term and multiyear research grants in the life sciences and will support collaborations with NUS, including a joint symposium to advance the exchange of scientific knowledge in the biological and physical sciences.
Financial and other details of the deal were not disclosed.
A year ago, the partners announced a collaboration with NUS' Environmental Research Institute to conduct metabolomic research into the water systems around Singapore.